chr11-66744819-G-GGGCGGC
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
The NM_001302084.2(TOP6BL):c.-109_-104dupCGGCGG variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 1,221,768 control chromosomes in the GnomAD database, including 6,888 homozygotes. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 1409 hom., cov: 0)
Exomes 𝑓: 0.12 ( 5479 hom. )
Consequence
TOP6BL
NM_001302084.2 5_prime_UTR
NM_001302084.2 5_prime_UTR
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.00
Genes affected
TOP6BL (HGNC:26197): (TOP6B like initiator of meiotic double strand breaks) Predicted to be involved in meiotic DNA double-strand break formation and reciprocal meiotic recombination. Predicted to be located in chromosome. Implicated in gestational trophoblastic neoplasm. [provided by Alliance of Genome Resources, Apr 2022]
SPTBN2 (HGNC:11276): (spectrin beta, non-erythrocytic 2) Spectrins are principle components of a cell's membrane-cytoskeleton and are composed of two alpha and two beta spectrin subunits. The protein encoded by this gene (SPTBN2), is called spectrin beta non-erythrocytic 2 or beta-III spectrin. It is related to, but distinct from, the beta-II spectrin gene which is also known as spectrin beta non-erythrocytic 1 (SPTBN1). SPTBN2 regulates the glutamate signaling pathway by stabilizing the glutamate transporter EAAT4 at the surface of the plasma membrane. Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.257 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOP6BL | NM_001302084.2 | c.-109_-104dupCGGCGG | 5_prime_UTR_variant | Exon 1 of 15 | ENST00000540737.7 | NP_001289013.1 | ||
TOP6BL | NM_024650.4 | c.-50_-45dupCGGCGG | 5_prime_UTR_variant | Exon 1 of 17 | NP_078926.4 | |||
SPTBN2 | XM_047427495.1 | c.-489_-484dupGCCGCC | upstream_gene_variant | XP_047283451.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.115 AC: 17005AN: 148098Hom.: 1406 Cov.: 0
GnomAD3 genomes
AF:
AC:
17005
AN:
148098
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0936 AC: 1411AN: 15072Hom.: 126 AF XY: 0.0883 AC XY: 807AN XY: 9136
GnomAD3 exomes
AF:
AC:
1411
AN:
15072
Hom.:
AF XY:
AC XY:
807
AN XY:
9136
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.122 AC: 130555AN: 1073568Hom.: 5479 Cov.: 31 AF XY: 0.121 AC XY: 62940AN XY: 519386
GnomAD4 exome
AF:
AC:
130555
AN:
1073568
Hom.:
Cov.:
31
AF XY:
AC XY:
62940
AN XY:
519386
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.115 AC: 17019AN: 148200Hom.: 1409 Cov.: 0 AF XY: 0.118 AC XY: 8527AN XY: 72194
GnomAD4 genome
AF:
AC:
17019
AN:
148200
Hom.:
Cov.:
0
AF XY:
AC XY:
8527
AN XY:
72194
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at